Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Monday's Intraday Session

Gainers

  • Opiant Pharma (NASDAQ:OPNT) stock increased by 112.9% to $20.22 during Monday's regular session. Trading volume for Opiant Pharma's stock is 1.0 million as of 12:30 EST. This is 7619.5% of its average full-day volume over the last 100 days. The company's market cap stands at $104.4 million. The company's, Q3 earnings came out today.
  • NeuBase Therapeutics (NASDAQ:NBSE) stock rose 42.82% to $0.31. Trading volume for this security as of 12:30 EST is 770.7K, which is 603.7% of its average full-day volume over the last 100 days. The company's market cap stands at $9.9 million.
  • PDS Biotechnology (NASDAQ:PDSB) shares moved upwards by 25.62% to $7.04. The current volume of 13.4 million shares is 5628.6% of PDS Biotechnology's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $200.2 million. The company's, Q3 earnings came out today.
  • Clovis Oncology (NASDAQ:CLVS) shares moved upwards by 24.1% to $0.36. Trading volume for this security as of 12:30 EST is 14.7 million, which is 400.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $51.9 million. The company's, Q3 earnings came out 3 days ago.
  • Cabaletta Bio (NASDAQ:CABA) stock moved upwards by 19.75% to $2.85. Trading volume for this security as of 12:30 EST is 838.1K, which is 41.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $82.6 million. The company's, Q3 earnings came out 2 days ago.
  • Cassava Sciences (NASDAQ:SAVA) shares rose 17.37% to $44.13. As of 12:30 EST, this security is trading at a volume of 2.4 million shares, making up 73.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.7 billion.
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.